Atlas Trials

Tolcapone in Obsessive Compulsive Disorder

Clinical trial NCT03348930 · COMPLETED

Trial details

NCT number
NCT03348930
Sponsor
University of Chicago
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Obsessive-Compulsive Disorder
Start date
2018-03-20
Primary completion
2020-12-14
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.